Evaluating the susceptibility to ceftazidime-avibactam in clinical isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa recovered from an apex medical hospital in north India
CZA/AVI shows good in-vitro activity against clinical isolates of <i>K. pneumoniae</i> and <i>P. aeruginosa</i> and can be part of empirical therapy for treating infections caused by these bacteria.
Authors
- T. Iskandar Faisal
- Qounser Nisar
- Biswajyoti Borkakoty (ORCID: https://orcid.org/0000-0002-6922-4198)
- Anjum Ara Mir (ORCID: https://orcid.org/0009-0002-8206-1108)
- Nargis Bali (ORCID: https://orcid.org/0000-0002-5117-4639)
- Roseleen Bali
- Zubair Teli
Institutions
- Apollo Hospitals (IN)
- Sher-i-Kashmir Institute of Medical Sciences (IN)
- Government College for Women Anantnag (IN)
- Regional Medical Research Centre (IN)
- Government Medical College (IN)
Publication Details
- Journal
- Iranian Journal of Microbiology
- Published
- 2025-04-12
- DOI
- https://doi.org/10.18502/ijm.v17i2.18385
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00